Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication

PHASE3CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions
Gastritis Associated With Helicobacter Pylori
Interventions
DRUG

vonoprazan 20 mg bid

Vonoprazan is potent acid inhibitor. Vonoprazan 20 mg is dosed twice daily for 1 week.

DRUG

Amoxicillin 500 mg tid

Amoxicillin is antibiotics. Its bactericidal effect is time-dependent. Then, 500 mg of amoxicillin is dosed three times daily for 1 week.

DRUG

Amoxicillin 750 mg bid

Amoxicillin is antibiotics. Its bactericidal effect is time-dependent. However, the standard regimen in Japan, 750 mg of amoxicillin is dosed twice daily with clarithromycin or metronidazole for 1 week. Then, 750 mg of amoxicillin is dosed twice daily.

DRUG

Clarithromycin 200 mg bid

Clarithromycin is antibiotics. It is involved in the standard first line regimen in Japan. Then, 200 mg of clarithromycin is dosed twice daily for 1 week.

DRUG

Metronidazole 250 mg bid

Metronidazole is antimicrobial agent. It is involved in the standard second line regimen in Japan. Then, 250 mg of metronidazole is dosed twice daily for 1 week.

Trial Locations (1)

431-3192

Hamamatsu University School of Medicine, Hamamatsu

All Listed Sponsors
lead

Hamamatsu University

OTHER

NCT02827942 - Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication | Biotech Hunter | Biotech Hunter